Review Article
Cell-Specific Aptamers as Emerging Therapeutics
Table 3
Aptamers for cell-specific delivery of drug molecules.
| Target molecule | Aptamer | Drug molecules linked or complexed with the aptamer | Lit. |
| PSMA | 2′-F-modified RNA | (1) siRNAs/shRNAs | (1) [88–92] | | | (2) Protein toxin gelonin | (2) [93] | | | (3) Dox | (3) [94] | | | (4) QDs, SPION or gold NPs with Dox | (4) [95–99] | | | (5) Pt(IV)-encapsulated PLGA-PEG NPs | (5) [100] | gp120 | 2′-F-modified RNA | siRNAs | [101, 102] | Nucleolin | DNA | PDT agent TMPyP4 | [103] | PTK7 | DNA | Dox | [104] | TfR | DNA | L-iduronidase | [105] | MUC1 | DNA | PDT agent chlorin | [106] | EGFR | RNA | Gold NPs | [107] | IgM heavy chain | DNA | Micelle-like nanostructures | [108] |
|
|